Rainbow Childrens Medicare Ratios

Rainbow Childrens Medicare Ltd Ratios

The Rainbow Childrens Medicare Ltd Ratios page provides a complete fundamental analysis of Rainbow Childrens Medicare Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Rainbow Childrens Medicare Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Rainbow Childrens Medicare Ltd (NSE: RAINBOW, BSE: 543524) is currently trading at ₹1114.30, with a market capitalization of ₹113.44B. As a major player in the Health services sector and Hospital/Nursing management industry, Rainbow Childrens Medicare Ltd remains a key stock for fundamental analysis using Rainbow Childrens Medicare Ltd Ratios.

Rainbow Childrens Medicare Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Rainbow Childrens Medicare Ltd P/E ratio currently stands at 58.71, making it one of the most tracked metrics in Rainbow Childrens Medicare Ltd Ratios.

Historically, the Rainbow Childrens Medicare Ltd P/E ratio has shown strong fluctuations:

• 2024: 58.71
• 2023: 60.87
• 2022: 34.97
• 2021: 0
• 2020: 0

The decline in Rainbow Childrens Medicare Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Rainbow Childrens Medicare Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 9.68.

Historical P/B trend:

• 2024: 9.68
• 2023: 10.47
• 2022: 6.99
• 2021: 0

Rainbow Childrens Medicare Ltd is trading at a premium to its book value, indicating strong market confidence.

Price to Sales Ratio (P/S)

The Rainbow Childrens Medicare Ltd P/S ratio currently stands at 9.39, an important part of Rainbow Childrens Medicare Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 9.39
• 2023: 10.18
• 2022: 6.28
• 2021: 0

A stable or declining Rainbow Childrens Medicare Ltd P/S ratio indicates cautious market sentiment.

Rainbow Childrens Medicare Ltd Price to Cash Flow Ratio (P/CF)

The Rainbow Childrens Medicare Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 34.07.

Historical Rainbow Childrens Medicare Ltd Price to Cash Flow Ratio:

• 2024: 34.07
• 2023: 38.34
• 2022: 21.58
• 2021: 0
• 2020: 0

The declining Rainbow Childrens Medicare Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Rainbow Childrens Medicare Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Rainbow Childrens Medicare Ltd EV currently stands at ₹143.13B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 143.13B
• 2023: 134.77B
• 2022: 75.66B
• 2021: 0

Rainbow Childrens Medicare Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.

EV/EBITDA Ratio

The Rainbow Childrens Medicare Ltd EV/EBITDA ratio is currently 28.66, a key metric in Rainbow Childrens Medicare Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 28.66
• 2023: 30.71
• 2022: 18.67
• 2021: 0

Stable Rainbow Childrens Medicare Ltd EV/EBITDA indicates balanced valuation.

Rainbow Childrens Medicare Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Rainbow Childrens Medicare Ltd D/E ratio is currently 0.52, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.52
• 2023: 0.61
• 2022: 0.54
• 2021: 0.96

Rainbow Childrens Medicare Ltd maintains moderate leverage with manageable risk.

Return on Equity (ROE %)

The Rainbow Childrens Medicare Ltd ROE currently stands at 17.85%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 17.85
• 2023: 18.72
• 2022: 25.36
• 2021: 26.36

Rainbow Childrens Medicare Ltd maintains stable profitability levels.

Rainbow Childrens Medicare Ltd Ratios Analysis Summary

The Rainbow Childrens Medicare Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Rainbow Childrens Medicare Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Rainbow Childrens Medicare Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.